Skip to content
10-K

Annual Report

MEDICINOVA, INC. MNOV

0001193125-26-100432

← back to feed
Filed
Mar 10, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Mar 5, 2026 49.22M sh
Shares Diluted FY 2025 · Dec 31, 2025 49.06M sh
Shares Diluted FY 2025 · Dec 31, 2024 49.05M sh
Capex FY 2025 · Dec 31, 2025 $2.9K
Capex FY 2025 · Dec 31, 2024 $895
Operating Cash Flow FY 2025 · Dec 31, 2025 −$9.81M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$10.64M
Cash And Equivalents FY 2025 · Dec 31, 2025 $30.81M
Cash And Equivalents FY 2025 · Dec 31, 2024 $40.36M
Stockholders Equity FY 2025 · Dec 31, 2025 $41.59M
Stockholders Equity FY 2025 · Dec 31, 2024 $52.5M
Stockholders Equity FY 2025 · Dec 31, 2023 $62.38M
Current Liabilities FY 2025 · Dec 31, 2025 $3.8M
Current Liabilities FY 2025 · Dec 31, 2024 $2.96M
Total Liabilities FY 2025 · Dec 31, 2025 $4.02M
Total Liabilities FY 2025 · Dec 31, 2024 $3.37M
Current Assets FY 2025 · Dec 31, 2025 $30.99M
Current Assets FY 2025 · Dec 31, 2024 $41.07M
Total Assets FY 2025 · Dec 31, 2025 $45.6M
Total Assets FY 2025 · Dec 31, 2024 $55.88M
Eps Diluted FY 2025 · Dec 31, 2025 −$0.24
Eps Diluted FY 2025 · Dec 31, 2024 −$0.23
Eps Basic FY 2025 · Dec 31, 2025 −$0.24
Eps Basic FY 2025 · Dec 31, 2024 −$0.23
Sga Expense FY 2025 · Dec 31, 2025 $6.16M
Sga Expense FY 2025 · Dec 31, 2024 $5.48M
Rd Expense FY 2025 · Dec 31, 2025 $6.7M
Rd Expense FY 2025 · Dec 31, 2024 $6.8M
Net Income FY 2025 · Dec 31, 2025 −$12M
Net Income FY 2025 · Dec 31, 2024 −$11.05M
Operating Income FY 2025 · Dec 31, 2025 −$13.28M
Operating Income FY 2025 · Dec 31, 2024 −$12.68M
Revenue FY 2025 · Dec 31, 2025 $409.66K